107. Juvenile idiopathic arthritis Clinical trials / Disease details


Clinical trials : 441 Drugs : 282 - (DrugBank : 56) / Drug target genes : 52 - Drug target pathways : 142

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2004-004153-25-GB
(EUCTR)
10/12/200417/02/2005Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with juvenile idiopathic arthritis (JIA) and growth failure. - rhGH in JIAEffect of recombinant growth hormone on growth and chondrocyte dynamics in children with juvenile idiopathic arthritis (JIA) and growth failure. - rhGH in JIA Growth retardation secondary to juvenile idiopathic arthritisTrade Name: Norditropin SimpleXx 5mg/1.5ml
Product Name: Norditropin SimpleXx
INN or Proposed INN: Somatropin
Other descriptive name: Growth Hormone
Royal Hospital For Sick Children, Yorkhill DivisionNULLNot RecruitingFemale: yes
Male: yes
United Kingdom
2NCT00420251
(ClinicalTrials.gov)
March 19969/1/2007Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic ArthritisRecombinant Human Growth Hormone Treatment in Juvenile Idiopathic Arthritis: Controlled Study on the Effect on Growth and Bone DevelopmentJuvenile Idiopathic Arthritis;Still Disease, Juvenile-OnsetDrug: GenotropinLudwig-Maximilians - University of MunichPfizerCompleted4 Years14 YearsBoth50Phase 3Germany
3EUCTR2014-004104-30-Outside-EU/EEA
(EUCTR)
01/04/2015Treatment With Recombinant Human Growth Hormone (Genotonorm) in Children With Short Stature Secondary to a Long Term Corticoid Therapy. A Study of Efficacy and SafetyTreatment With Recombinant Human Growth Hormone (Genotonorm) in Children With Short Stature Secondary to a Long Term Corticoid Therapy. A Study of Efficacy and Safety Juvenile idiopathic arthritis (JIA) and nephrotic syndrome (NeS);Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]Product Name: Genotropin
INN or Proposed INN: Somatropin
Other descriptive name: SOMATROPIN
Pharmacia & Upjohn S.A.NULLNAFemale: yes
Male: yes
30France
4EUCTR2014-004105-32-Outside-EU/EEA
(EUCTR)
01/04/2015Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With Chronic Juvenile Arthritis (CJA) Treated by Corticosteroid TherapyPrevention of Retarded Growth by Early Treatment With Recombinant Human Growth Factor (Genotonorm) in Children With Systemic Forms of Chronic Juvenile Arthritis Receiving Long-Term Corticosteroid Therapy. Extension of the Study Beyond Three Years. Juvenile idiopathic arthritis (JIA);Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]Product Name: Genotropin
INN or Proposed INN: Somatropin
Other descriptive name: SOMATROPIN
Pfizer IncNULLNAFemale: yes
Male: yes
21France